Unlike Guida and coworkers, the latter researchers found, by immunohistochemistry, an increase in CB1 expression, but no change in CB2 expression in stage 1 endometrial carcinoma tissue compared to normal endometrial tissue [117]. This evidence concerns the gene CNR1 and endometrial carcinoma.